ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Palantir Technologies Inc

Palantir Technologies Inc (PLTR)

64,65
0,00
(0,00%)
Fermé 23 Janvier 10:00PM
64,65
0,00
( 0,00% )
Avant marché: 1:00AM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
64,65
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
Clôture Veille
64,65
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
2 277 016 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
701,95
Bénéfice par action (BPA)
0,09
Chiffre d'affairess
2,23B
Bénéfice net
209,83M

À propos de Palantir Technologies Inc

Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Pal... Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers. Show more

Secteur
Prepackaged Software
Industrie
Prepackaged Software
Siège social
Wilmington, Delaware, USA
Fondé
-

PLTR Dernières nouvelles

U.S. National Institutes of Health Recommend to Expand Its Scope of Research in the Development of Pluristem's PLX-RAD Cells fo

HAIFA, Israel, July 18, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the U.S...

Pluristem Completes Enrollment for Phase I/II Muscle Injury Trial

HAIFA, Israel, July 11, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today it has completed the...

Pluristem's South Korean Partner Files IND With Korean FDA for PLX Cells

HAIFA, Israel, July 8, 2013 (GLOBE NEWSWIRE) -- On the heels of announcing its strategic partnership agreement with Cha Bio&Diostech (Kosdaq:CHA) on June 26th, Pluristem Therapeutics Inc...

Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercializa

HAIFA, Israel, June 26, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced that its wholly owned subsidiary, Pluristem Ltd., has entered into an...

Pluristem's Preclinical Results for Its PLX-RAD Cells Published in the Journal PLOS ONE

HAIFA, Israel, June 20, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that preclinical...

Pluristem Provides Update on Clinical Status of IC Trials

HAIFA, Israel, June 19, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, provided an update today on the...

Pluristem to Deliver Two Presentations During Israel's Largest Biotech Conference: IATI-BioMed

HAIFA, Israel, June 10, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Pluristem's CEO...

Pluristem to Receive Clinical-hold Notice From the U.S. FDA

HAIFA, Israel, June 4, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that it has received...

Pluristem to Present at FDA Symposium

HAIFA, Israel, May 29, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company has...

Pluristem Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nucl

HAIFA, Israel, May 22, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that Katherina Reiche...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

PLTR - Frequently Asked Questions (FAQ)

What is the current Palantir Technologies share price?
The current share price of Palantir Technologies is US$ 64,65
How many Palantir Technologies shares are in issue?
Palantir Technologies has 2 277 016 000 shares in issue
What is the market cap of Palantir Technologies?
The market capitalisation of Palantir Technologies is USD 147,21B
What is the 1 year trading range for Palantir Technologies share price?
Palantir Technologies has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Palantir Technologies?
The price to earnings ratio of Palantir Technologies is 701,95
What is the cash to sales ratio of Palantir Technologies?
The cash to sales ratio of Palantir Technologies is 66,16
What is the reporting currency for Palantir Technologies?
Palantir Technologies reports financial results in USD
What is the latest annual turnover for Palantir Technologies?
The latest annual turnover of Palantir Technologies is USD 2,23B
What is the latest annual profit for Palantir Technologies?
The latest annual profit of Palantir Technologies is USD 209,83M
What is the registered address of Palantir Technologies?
The registered address for Palantir Technologies is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Palantir Technologies website address?
The website address for Palantir Technologies is www.palantir.com.
Which industry sector does Palantir Technologies operate in?
Palantir Technologies operates in the PREPACKAGED SOFTWARE sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
VNCEVince Holding Corp
US$ 3,185
(35,53%)
896,35k
MCIBarings Corporate Investors
US$ 27,09
(31,12%)
6
ALTGAlta Equipment Group Inc
US$ 8,99
(23,49%)
1
FVRFrontView Reit Inc
US$ 20,99
(21,54%)
5
AUNAAuna SA
US$ 9,99
(21,24%)
1
EVTLVertical Aerospace Ltd
US$ 6,40
(-31,03%)
13,79k
BSACBanco Santander Chile
US$ 15,10
(-23,78%)
100
NBHCNational Bank Holdings Corporation
US$ 34,00
(-21,95%)
2
AMTBAmerant Bancorp Inc
US$ 18,00
(-19,64%)
3
MPXMarine Products Corp
US$ 7,22
(-19,42%)
104
VNCEVince Holding Corp
US$ 3,185
(35,53%)
896,35k
QBTSD Wave Quantum Inc
US$ 5,98
(-4,32%)
532,29k
BBAIBigBear ai Holdings Inc
US$ 4,19
(-5,63%)
199,57k
SESSES AI Corporation
US$ 0,8689
(4,51%)
195,7k
OKLOOklo Inc
US$ 32,12
(-6,00%)
133,83k
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées